Insider Transactions Reported by 25 Insiders of Longeveron Inc.

Symbol
LGVN on Nasdaq
Location
Miami, FL

Insiders trading volume in the past year

Longeveron Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Donald M. Soffer Director $8,761,432 21 Dec 2022
Joshua Hare Chief Scientific Officer, Director, 10%+ Owner $1,012,896 -$7,367 -0.72% 15 Jul 2025
Mohamed Wa'el Ahmed Hashad Chief Executive Officer $564,011 15 Jul 2025
Rock Soffer Director $302,885 -$29,390 -8.8% 15 Jul 2025
Paul T. Lehr General Counsel, Secretary $204,096 02 Jan 2026
Kwan-Hong Christopher Min Chief Medical Officer $198,924 04 Apr 2022
Geoff Green Ceo $175,267 04 Apr 2022
Lisa Locklear Chief Financial Officer $135,696 02 Jan 2026
Nataliya Agafonova Chief Medical Officer $128,422 02 Jan 2026
Devin Blass CTO & SVP of CMC $118,704 02 Jan 2026
James Nathaniel Powell Chief Executive Officer $74,476 02 Jan 2026
James Clavijo CFO and Treasurer $61,915 27 Jun 2023
Ursula Ungaro Director $54,940 15 Jul 2025
Neil E. Hare Director $50,813 15 Aug 2024
Richard N. Kender Director $44,220 15 Jul 2025
Roger Joseph Hajjar Director $44,220 15 Jul 2025
Neha J. Motwani Director $44,220 15 Jul 2025
Khoso Baluch Director $43,588 11 Aug 2025
George A. Paletta Jr. Director $25,591 01 Oct 2025
JEFFREY PFEFFER Director $20,250 28 Dec 2023
Cathy Ross Director $13,089 10 Jan 2024
Todd Girolamo Director $6,545 21 Dec 2022
DOUGLAS W. LOSORDO Director 21 Dec 2023
Erin Borger Director 21 Dec 2022
DS MED LLC 10%+ Owner 17 May 2022

Recent Insider Transactions by Companies or Individuals for Longeveron Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.